GenVec’s loss increases in 4th quarter

GenVec Inc., of Gaithersburg, a biopharmaceutical company developing novel gene-based drugs and vaccines, reported a fourth-quarter net loss totaling $3.2 million, or 26 percent more than the net loss of $2.5 million it reported in the 2011 quarter.

Leave a Reply

Your email address will not be published. Required fields are marked *